Nancy Lurker's Net Worth
$6.88 Million
Who is Nancy Lurker?
Nancy Lurker has an estimated net worth of $6.88 Million. This is based on reported shares across multiple companies, which include EyePoint Pharmaceuticals, Inc., PDI INC, Mallinckrodt plc, Aquestive Therapeutics, Inc., and AUXILIUM PHARMACEUTICALS INC.
SEC CIK
Nancy Lurker's CIK is 0001450485
Past Insider Trading and Trends
2023 was Nancy Lurker's most active year for acquiring shares with 13 total transactions. Nancy Lurker's most active month to acquire stocks was the month of May. 2023 was Nancy Lurker's most active year for disposing of shares, totalling 10 transactions. Nancy Lurker's most active month to dispose stocks was the month of January. 2014 saw Nancy Lurker paying a total of $491,650.00 for 38,146 shares, this is the most they've acquired in one year. In 2014 Nancy Lurker cashed out on 58,401 shares for a total of $1,170,541.45, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EyePoint Pharmaceuticals, Inc. (EYPT) Snapshot price: $29.35
Executive Vice Chair
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.04% | 22.59K |
$28.80 | -$430,358.40 | 210.24K |
Feb 9 - Feb 13
| |||
Form 4
| -20.53% | -35.00K |
$24.98 | -$874,199.64 | 135.44K |
Jan 23 - Jan 24
| |||
Form 4
| +44.01% | 52.09K |
$20.40 | -$470,077.20 | 170.44K |
Jan 5 - Jan 6
| |||
Form 4/A
|
—
|
0
|
—
|
—
| 170.56K |
Dec 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 4
| -10.50% | -20.00K |
$20.76 | -$415,200.00 | 170.56K |
Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| +24.53% | 37.53K |
—
|
—
| 190.56K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
| +9.05% | 12.47K |
—
|
—
| 150.28K |
Feb 28
| |||
Form 4
| +11.05% | 13.72K |
—
|
—
| 137.81K |
Feb 21
| |||
Form 4
| +16.45% | 17.53K |
—
|
—
| 124.1K |
Feb 9
| |||
Form 4
| -8.81% | -10.00K |
$20.15 | -$201,480.00 | 103.55K |
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +4.13% | 4.5K |
—
|
—
| 113.55K |
Jun 14
| |||
Form 4
| +12.91% | 12.47K |
—
|
—
| 109.05K |
Feb 28
| |||
Form 4
| +16.55% | 13.72K |
—
|
—
| 96.58K |
Feb 21
| |||
Form 4
| +18.89% | 124.67K |
—
|
—
| 784.47K |
Jun 30
| |||
Form 4
| +6.45% | 40K |
—
|
—
| 659.8K |
Jun 27
| |||
Form 4
| +7.83% | 45K |
—
|
—
| 619.8K |
Jun 14
| |||
Form 4
| +20.55% | 98K |
$1.06 | $104,027.00 | 574.8K |
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +40.39% | 137.17K |
—
|
—
| 476.8K |
Feb 21
| |||
Form 4
| -3.30% | -10.74K |
$2.11 | -$22,618.22 | 314.45K |
Oct 12
| |||
Form 4
| +14.03% | 40K |
—
|
—
| 325.2K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
| +18.73% | 45K |
—
|
—
| 285.2K |
Jun 14
| |||
Form 4
| +13.46% | 28.5K |
$1.76 | $50,245.50 | 240.2K |
Mar 29
| |||
Form 4
| +56.78% | 76.67K |
—
|
—
| 211.7K |
Oct 12
| |||
Form 4
| +42.09% | 40K |
—
|
—
| 135.03K |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
| +67.61% | 38.33K |
—
|
—
| 95.03K |
Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
∞
| 56.7K |
$1.76 | $99,962.10 | 56.7K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PDI INC (IDXG) Snapshot price: $1.0175
CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mallinckrodt plc (MNKTQ) Snapshot price: $0.12
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.75% | 3.58K |
$55.69 | -$25,506.02 | 10.51K |
Mar 16
| |||
Form 4
| +32.92% | 1.72K |
—
|
—
| 6.92K |
Mar 19
| |||
Form 4
| +12.34% | 572 |
—
|
—
| 5.21K |
May 22
| |||
Form 4
| +52.83% | 1.6K |
$69.95 | -$67,921.45 | 4.64K |
Mar 20
| |||
Form 4
|
∞
| 3.03K |
—
|
—
| 3.03K |
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aquestive Therapeutics, Inc. (AQST) Snapshot price: $2.66
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AUXILIUM PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
$36.53 | -$365,300.00 |
0
|
Jan 29
| |||
Form 4
| -42.63% | -7.43K |
$26.84 | -$610,970.00 | 10K |
Dec 5
| |||
Form 4
| +40.23% | 5K |
—
|
—
| 17.43K |
May 21
| |||
Form 4
| +67.29% | 5K |
—
|
—
| 12.43K |
May 1
| |||
Form 4
| +5.95% | 417 |
$26.89 | $11,213.13 | 7.43K |
Jun 29
| |||
Form 4
| +248.39% | 5K |
—
|
—
| 7.01K |
Jun 21
| |||
Form 4
| +42.97% | 605 |
$18.57 | $11,234.85 | 2.01K |
Mar 30
| |||
Form 4
| +66.63% | 563 |
$19.93 | $11,220.59 | 1.41K |
Dec 30
| |||
Form 4
| +789.47% | 750 |
$14.99 | $11,242.50 | 845 |
Sep 30
| |||
Form 4
|
∞
| 95 |
$19.60 | $1,862.00 | 95 |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||